We innovate, develop & market products for a sustainable healthy life.
Magle PharmaCept continuously strives to innovate and bring life changing solutions to patients in need. Magle PharmaCept collaborates with healthcare professionals and research institutions to develop products and solutions to offer patients optimal therapy options. Visit Magle PharmaCept to learn more about us, the DSM technology and our products.

About Magle Group
Magle AB (formed in 1995 as a pure development company) acquired Chemoswed AB (formed in 1944 as a manufacturing company) in 2016 before merging the companies in 2017 to form Magle Chemoswed. In 2019, Adroit Science AB was acquired to increase the development services segment. In 2021, PharmaCept GmbH was acquired as a first step to develop a sales and marketing organization for DSM products. In 2024 Magle Group welcomed Magle Biopolymers - a CDMO part of the group focusing on Dextran technology, and Magle BioPharma - a stem cell based CDMO.
Already working at Magle Group?
Let’s recruit together and find your next colleague.